Most clinical studies take the function of drugs modulating by means of NMDA receptors. Ketamine is noncompetitive voltage-dependent NMDA-receptor channel blocker whose antidepressant action is apparent at low doses, and with growing doses, it mimics psychotomimetic action and eventually contributes